Trials (Charité Comprehensive Cancer Center): Revision history

14 December 2025

• curprev 20:3620:36, 14 December 2025‎ Francine talk contribs‎ 76,687 bytes +193‎ No edit summary undo

6 December 2025

• curprev 12:4012:40, 6 December 2025‎ Lucas talk contribs‎ m 76,494 bytes +1,701‎ Update categories. undo

3 December 2025

• curprev 02:4502:45, 3 December 2025‎ Larysse talk contribs‎ 74,793 bytes +49‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 74,744 bytes +90‎ Update categories. undo

4 December 2023

• curprev 13:0613:06, 4 December 2023‎ Francine talk contribs‎ 74,654 bytes +74,654‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Charité Comprehensive Cancer Center page '''NCTID''': NCT02951767 '''Title''': A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) '''Study Summary''': This Phase II, single-arm study is designed to evaluate the effect of atezolizumab treatment in participants with locally advanced or metastatic urothelial bladder cancer. Participants will..."